Skip to content

2-Year Diploma · Udupi

D.Pharm at Manipal College of Pharmaceutical Sciences

A 2-year fast lane into pharmacy from NIRF India’s #8 ranked pharmacy school. Merit-based entry, zero entrance exam stress.

NAAC Grade

A++ (3.83)

Top-tier institutional accreditation

Key numbers

Duration

24 Months

NIRF Pharmacy Rank

#8

Batch Size

60 Seats

Placement Rate

70%

Average CTC

₹2.8 LPA

Investment

3.0L total

~₹1.5L per year

  • Tuition Fee1,50,000per year

Are you eligible?

  • Class 12 Subjects

    Physics, Chemistry, and Mathematics or Biology

  • Minimum Marks

    At least 50% aggregate in Class 12

  • Admission Basis

    Purely merit-based; no entrance exam required

Placement · 2025

Where graduates land

Placement rate

70%

Top recruiters

Apollo PharmacyMedPlusNetmedsLocal pharmaceutical companies

Your 2-Year D.Pharm Roadmap

  1. Year +0

    Year 1: Build the Basics

    Pharmaceutics, Pharmaceutical Chemistry, Pharmacology + intensive practicals

  2. Year +1

    Year 2: Clinical & Law

    Hospital & Clinical Pharmacy, Pharmacy Law & Ethics, advanced training

  3. Year +2

    Post-Diploma

    Enter retail/hospital pharmacy or secure lateral entry into B.Pharm

info

Hostel Available, But No Scholarships

On-campus hostel accommodation is an option, but scholarship support isn’t offered for this diploma. Factor in living costs on top of the ₹3 lakh total tuition when you budget.

The verdict

Good fit

If you want a quick, reputable entry into pharmacy without an entrance exam grind, this 2-year D.Pharm from an NIRF top-10 institution is a solid launchpad. The 70% placement rate into recognizable retail and e-pharma brands is promising, but remember: it’s a diploma, so upskilling or a lateral B.Pharm will likely be needed for long-term growth.

Matches what you said

  • Fast-track 2-year diploma
  • Merit-based admission with no entrance exam
  • Strong institutional brand & NIRF #8 rank

Doesn't match

  • Immediate full bachelor's degree
  • Scholarship support
  • Research or high-salary pharma R&D roles straight out
1 / 9